Bardzo tanie apteki z dostawą w całej Polsce kupic cialis i ogromny wybór pigułek.

Microsoft word - cv-carloalessandria-sett2013.doc

CURRICULUM VITAE
Dottor CARLO ALESSANDRIA
DATI PERSONALI

Cognome:
ALESSANDRIA
Data di nascita:
06 Gennaio 1974
Luogo di nascita:
Nazionalità:
Italiana
Professione:
MEDICO CHIRURGO
Specialista in:
GASTROENTEROLOGIA ED ENDOSCOPIA DIGESTIVA
DATI ACCADEMICI e ATTIVITA' PROFESSIONALE
Laurea in Medicina e Chirurgia
Titolo della Tesi di Laurea: “ Alterazione della funzione renale nel paziente cirrotico. Ruolo della terlipressina nell’approccio diagnostico e terapeutico”. Punteggio: centosei su centodieci (106/110) Specializzazione in Gastroenterologia ed Endoscopia Digestiva
Data di Specializzazione: 16 Dicembre 2003 Titolo della Tesi di Specializzazione: “Efficacia della terlipressina nella prevenzione della disfunzione circolatoria post- paracentesi nella cirrosi epatica. Uno studio pilota”. Punteggio: settanta settantesimi (70/70) con lode Frequenza di un anno (Settembre 2002-Settembre 2003) presso la Università di Barcelona, Servizio di Epatologia
dell’Hospital Clínic i Provincial de Barcelona – Gruppo di Studio “Fisiopatologia e trattamento della ascite e delle
alterazioni della funzione renale nella cirrosi epatica” (Direttori: Prof. Vicente Arroyo, Prof. Pere Ginès). Da giugno 2007 Dirigente Medico di I livello presso la Divisione di Gastroenterologia ed Epatologia dell’Ospedale San
Giovanni Battista (Molinette) di Torino (Direttore: Prof. Mario Rizzetto).
PREMI E ALTRE ESPERIENZE
Gastroenterologia ed Epatologia
- Premio AISF 2009: "Migliore comunicazione orale clinical ". Alessandria C, Mezzabotta L, Carello M, Debernardi-
Venon W, Martini S, Rizzetto M, Marzano A. “Relative adrenal insufficiency in cirrhosis: Relevance in patients with
ascites and treatment with hydrocortisone in refractory ascites”. Roma, congresso annuale AISF 2009.
- Attività di tutor nei Corsi SIGE-AISF: "Ipertensione Portale" (2006) ed "Emergenze in Epatologia" (2009)
- Lettura EASL 2010 Postgraduate course “Management of acute clinical conditions in hepatology”. “ADRENAL
DYSFUNCTION IN ACUTE AND ACUTE ON CHRONIC LIVER FAILURE. A POTENTIAL TARGET FOR TREATMENT”. 45th Annual Meeting of the European Association of the Study of the Liver, Vienna 2010.
- Lettura EASL-CLIF 2012 Workshop “Bacterial Infections as a cause of Acute on Chronic Liver Failure”. "Adrenal
insufficiency in liver failure. Is it relevant and should it be treated?”. 47th Annual Meeting of the European Association
of the Study of the Liver, Barcelona 2012.
- Lettura EASL-ICA 2013 Workshop “The use of albumin in cirrhosis with ascites: a risk of spread between
guidelines and clinical practice?”. “Potential strategies to limit the use of albumin in therapeutic paracentesis”. 48th
Annual Meeting of the European Association of the Study of the Liver, Amsterdam 2013.
- Membro del comitato scientifico dell'International Club of Ascites da aprile 2011 a settembre 2013
Disturbi dello spettro autistico
- Dal 2010 esperienza di trattamento di bambini affetti da disturbo dello spettro autistico, con particolare riguardo alle problematiche gastrointestinali ad esso correlate - Terapia chelante con DMPS ed EDTA
- Supplementazione nutrizionale
- Diete specifiche
- “La Terapia Chelante” Workshop 2012, Facoltà di Medicina e Chirurgia - Università degli Studi di Milano
- ACAM's (American College for Advancement in Medicine) Fall 2012 Conference. Chelation Therapy Workshop, 2012,
- Advanced Medicine Seminars, 2012 Houston, Texas, USA
Comunicazioni orali in congressi scientifici
- Alessandria C, Debernardi-Venon W, Marzano A, et al. Alterazione della funzionalità renale nel paziente cirrotico.
Ruolo della terlipressina nell’approccio diagnostico e terapeutico. Torino, Monotematica AISF 1999.
- Alessandria C, Ozdogan O, Guevara M, Ginès P, Restuccia T, de las Heras D, Colmenero J, Calahorra B, Arroyo V,
Rodés J. Evolución y factores predictivos de supervivencia del Síndrome hepatorenal (SHR). Importancia del sodio sérico.
Barcelona, XXVIII Congreso nacional de la Asociación Española para el estudio del hígado. Gastroenterol Hepatol
2003; 26 (Supl 2): 54.


- Alessandria C
, Marzano A, Todros L, Morgando A, Mengozzi G, Debernardi-Venon W, Martini S, Rizzetto M. Low vs
standard albumin dosages in the prevention of paracentesis induced circulatory dysfunction: a randomized pilot study.
Roma, Congresso annuale AISF 2005. Dig Liver Dis 2005; 37: A31.

- Alessandria C
, Marzano A, Ottobrelli A, Debernardi-Venon W, Todros L, Torrani M, Morgando A, Balzola F, Martini S,
Cacace G, Rizzetto M. Noradrenalin vs terlipressin in hepatorenal syndrome: a prospective, randomized study. Roma,
Congresso annuale AISF 2006. Dig Liver Dis 2006; 38: A39.


- Alessandria C, Mezzabotta L, Carello M, Debernardi-Venon W, Martini S, Rizzetto M, Marzano A. Relative adrenal
insufficiency in cirrhosis: Relevance in patients with ascites and treatment with hydrocortisone in refractory ascites. 44th
Annual Meeting of the European Association of the Study of the Liver, Copenhagen 2009.


- Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, Morgando A, Marzano A, Rizzetto M. Adrenal
dysfunction in nonseptic cirrhotic patients with ascites: effects on survival. 46th Annual Meeting of the European
Association of the Study of the Liver, Berlin 2011.

PUBBLICAZIONI
1. Gaia S, Alessandria C, Marzano A, Rizzetto M. Polycistic Liver Disease. Liver Transpl 2001; 7(10):912.
2. Debernardi-Venon W, Barletti C, Alessandria C, Marzano A, Baronio M, Todros L, Saracco G, Rizzetto M. Efficacy
of Irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension. Dig Dis Sci 2002; 47: 401-404.
3. Alessandria C, Debernardi-Venon W, Marzano A, Barletti C, Fadda M, Rizzetto M. Renal failure in cirrhotic patients:
role of terlipressin in clinical approach to hepatorenal síndrome type 2. Eur J Gastroenterol Hepatol 2002; 14(12):1363-8.
4. Restuccia T, Ortega R, Guevara M, Ginès P, Alessandria C, Ozdogan O, Navasa M, Rimola A, Garcia-Valdecasas JC,
Arroyo V, Rodés J. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol 2004; 40 (1): 140-6.
5. Guevara M, Alessandria C, Uriz J. Transjugular intrahepatic portosystemic shunt and refractory ascites. Gastroenterol

6. Alessandria C, Gaia S, Marzano A, Debernardi Venon W, Fadda M, Rizzetto M. Application of the Model for End-
Stage Liver Disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment. Eur J Gastroenterol Hepatol 2004; 16 (6): 607-12.
7. Restuccia T, Gómez-Ansón B, Guevara M, Alessandria C, Torre A, Terra C, Martín M, Castellví M, Rami L, Sainz A,
Ginès P, Arroyo V. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology 2004; 39 (6): 1613-22.
8. Guevara M, Fernandez-Esparrach G, Alessandria C, Torre A, Terra C, Montana X, Piera C, Alvarez ML, Jiménez W,
GinèS p, Arroyo V. Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology 2004; 40 (3): 646-51.
9. Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W, Alessandria C, Franchello A. Salizzoni
M, Rizzetto M. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl 2005; 11 (4): 402-409.
10. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J, Ginès P. MELD score and
clinical type predict prognosis in hepatorenal sindrome. Relevance to liver transplantation. Hepatology 2005; 41 (6): 1282-9.
11. Ceretto S, Alessandria C, Rizzetto M, Marzano A. Bacterial overgrowth in intestinal lipomatosis with
pandiverticulosis. Clin Gastroenterol Hepatol 2007 Jul;5(7):A30.
12. Debernardi-Venon W, Martini S, Biasi F, Vizio B, Termine A, Poli G, Brunello F, Alessandria C, Bonardi R, Saracco
G, Rizzetto M, Marzano A. AT1 receptor antagonist Candesartan in selected cirrhotic patients: Effect on portal pressure and liver fibrosis markers. J Hepatol 2007; 46(6):1026-33.
13. Alessandria C, Ottobrelli A, Debernardi-Venon W, Todros L, Torrani Cerenzia M, Martini S, Balzola F, Morgando A,
Rizzetto M, Marzano A. Noradrenalin verus terlipressin in patients with hepatorenal sindrome: a prospective, randomized, unblinded, pilot study. J Hepatol 2007; 47(4):499-505.
14. Alessandria C, Debernardi-Venon W, Rizzetto M, Marzano A. Transjugular liver biopsy: a relatively simple procedure
with an indefinite past and an expected brilliant future. J Hepatol 2008; 48(1):171.172.
15. Marzano A, Alessandria C, Rizzetto M. Definition of hepatitis B infection for the best practice in chronic disease and
in immunosuppressed patients. J Hepatol 2008; 48(3):516-16.
16. Gaia S, Barbon, Smedile A, Olivero A, Carenzi S, Lagget M, Alessandria C et al. Lamivudine-resistant chronic
hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine. J Hepatol. 2008 Apr;48(4):540-7.
17. Alessandria C, Debernardi-Venon W, Carello M, Ceretto S, Rizzetto M, Marzano A. Midodrine in the prevention of
hepatorenal syndrome type 2 recurrence: a case-control study. Dig Liver Dis 2009; 41 298-302.
18. Alessandria C, Elia C, Mezzabotta L, Risso A, et al. Prevention of paracentesis-induced circulatory dysfunction in
cirrhosis: standars vs half albumin doses. A prospective, randomized, unblinded pilot study. Dig Liver Dis 2011; 43 (11): 881-6.
19. Marzano A, Marengo A, Ruggiero T, Allice T, Sanna C, Alessandria C, Morgando A, Sciandrello MC, Franzin AM,
Rizzetto M, Ghisetti V. Clinical impact of A/H1/N1/09 influenza in patients with cirrhosis: experience froma a nosocomial cluster of infection. J Med Virol. 2013; 85 (1): 1-7. 20. Angeli P, Sanyal A, Moeller S, Alessandria C et al. Current limits and future challenges in the management of renal
dysfunction in patients with cirrhosis: report from the International Club of Ascites. Liver Int. 2013; 33 (1): 16-23. 21. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V; CANONIC Study Investigators
of the EASL-CLIF Consortium. Acute-on-Chronic Liver Failure is a distinct syndrome that develops in patients with
acute deompensation of cirrhosis. Gastroenterology 2013; 44 (7): 1426-37.

Source: http://www.dottcarloalessandria.it/wp-content/uploads/2013/10/CV-CarloAlessandria-Sett2013.pdf

Tfjd344-05-147885.tex

STRAIN ENCODED (SENC) IMAGING FOR DETECTION OF REGIONAL DYSFUNCTION IN PATIENTS WITH MYOCARDIAL INFARCTION AT 3T Li Pan, MS,1 Ahmed S. Fahmy, MS,2 Amy Spooner, MD,1 Robert G. Weiss, MD,1 Matthias Stuber, PhD,1 Nael F. Osman, PhD.1 1 Johns Hopkins School of Medicine, Bal- timore, MD, USA, 2 Johns Hopkins University, Baltimore, MD, USA. (a) Longitudinal strain measurments by segment

schmc.ac.kr

This article was downloaded by:[Hong, Sae-Yong]On: 29 June 2008Access Details: [subscription number 794486449]Publisher: Informa HealthcareInforma Ltd Registered in England and Wales Registered Number: 1072954Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UKPublication details, including instructions for authors and subscription information:Association between plasma

Copyright © 2010-2014 Medical Articles